- Home
- LDWY vs KAPA Comparison
LDWY vs KAPA Comparison
Compare LDWY & KAPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDWY
- KAPA
- Stock Information
- Founded
- LDWY 1990
- KAPA 2013
- Country
- LDWY United States
- KAPA United States
- Employees
- LDWY N/A
- KAPA N/A
- Industry
- LDWY Advertising
- KAPA
- Sector
- LDWY Consumer Discretionary
- KAPA
- Exchange
- LDWY Nasdaq
- KAPA NYSE
- Market Cap
- LDWY 9.2M
- KAPA 9.1M
- IPO Year
- LDWY 1991
- KAPA 2024
- Fundamental
- Price
- LDWY $4.90
- KAPA $0.66
- Analyst Decision
- LDWY
- KAPA Strong Buy
- Analyst Count
- LDWY 0
- KAPA 3
- Target Price
- LDWY N/A
- KAPA $8.33
- AVG Volume (30 Days)
- LDWY 6.5K
- KAPA 2.2M
- Earning Date
- LDWY 08-18-2025
- KAPA 08-23-2025
- Dividend Yield
- LDWY N/A
- KAPA N/A
- EPS Growth
- LDWY N/A
- KAPA N/A
- EPS
- LDWY N/A
- KAPA N/A
- Revenue
- LDWY $42,183,000.00
- KAPA N/A
- Revenue This Year
- LDWY N/A
- KAPA N/A
- Revenue Next Year
- LDWY N/A
- KAPA N/A
- P/E Ratio
- LDWY N/A
- KAPA N/A
- Revenue Growth
- LDWY 425.12
- KAPA N/A
- 52 Week Low
- LDWY $3.02
- KAPA $0.40
- 52 Week High
- LDWY $5.53
- KAPA $4.00
- Technical
- Relative Strength Index (RSI)
- LDWY 50.82
- KAPA N/A
- Support Level
- LDWY $4.85
- KAPA N/A
- Resistance Level
- LDWY $5.12
- KAPA N/A
- Average True Range (ATR)
- LDWY 0.16
- KAPA 0.00
- MACD
- LDWY -0.05
- KAPA 0.00
- Stochastic Oscillator
- LDWY 7.84
- KAPA 0.00
About LDWY Lendway Inc. (DE)
Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two industries: Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.
About KAPA KAIROS PHARMA LTD
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.